NEW YORK (GenomeWeb News) – PerkinElmer reduced its headcount by 30 employees in the third quarter, the company said in a regulatory document this week.

PerkinElmer said that its management approved a plan during the quarter to shift some of its R&D resources into a newly opened Center for Innovation, resulting in the layoffs. It added in its quarterly financial document filed with the US Securities and Exchange Commission that all employees were notified of their termination by Sept. 29.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.